Affordable Insulin Now Act
Great Seal of the United States
Long titleAn Act to amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to establish requirements with respect to cost-sharing for certain insulin products, and for other purposes.
Announced inthe 117th United States Congress
Number of co-sponsors28
Legislative history

The Affordable Insulin Now Act is a bill in the United States Congress intended to cap out-of-pocket insulin prices under private health insurance and Medicare at no more than $35 per month.[1]

The bill was first introduced on February 25, 2022, by Representative Angie Craig (D-MN).[2] On March 31, 2022, the bill passed the House of Representatives, 232–193.[3][4][5]

References

  1. ↑ "Sen. King advocates for bill to cap insulin cost". newscentermaine.com. March 23, 2022. Retrieved 2022-03-30.
  2. ↑ Craig, Angie (2022-02-25). "H.R.6833 - 117th Congress (2021-2022): Affordable Insulin Now Act". www.congress.gov. Retrieved 2022-03-30.
  3. ↑ "Affordable Insulin Now Act could lower insulin cost to $35". 10tv.com. March 31, 2022. Retrieved 2022-04-01.
  4. ↑ Washington, U. S. Capitol Room H154; p:225-7000, DC 20515-6601 (2022-03-31). "Roll Call 102 Roll Call 102, Bill Number: H. R. 6833, 117th Congress, 2nd Session". Office of the Clerk, U.S. House of Representatives. Retrieved 2022-04-01.{{cite web}}: CS1 maint: numeric names: authors list (link)
  5. ↑ "Insulin Gets Step Closer to $35 Cap as House Passes Measures". MSN. 31 March 2022. Retrieved 2022-04-01.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.